136 related articles for article (PubMed ID: 34760638)
1. Rapid screening for mutations associated with malignant hyperthermia using high-resolution melting curve analysis.
Su IM; Wang PK; Chen CY; Huang HT; Day YJ
Tzu Chi Med J; 2021; 33(4):399-405. PubMed ID: 34760638
[TBL] [Abstract][Full Text] [Related]
2. Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis.
Broman M; Heinecke K; Islander G; Schuster F; Glahn K; Bodelsson M; Treves S; Müller C
Anesth Analg; 2011 Nov; 113(5):1120-8. PubMed ID: 21965348
[TBL] [Abstract][Full Text] [Related]
3. Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System.
Grievink H; Stowell KM
Anal Biochem; 2008 Mar; 374(2):396-404. PubMed ID: 18082125
[TBL] [Abstract][Full Text] [Related]
4. Detection of monoclonal immunoglobulin heavy chain gene rearrangement (FR3) in Thai malignant lymphoma by High Resolution Melting curve analysis.
Kummalue T; Chuphrom A; Sukpanichanant S; Pongpruttipan T; Sukpanichanant S
Diagn Pathol; 2010 May; 5():31. PubMed ID: 20482846
[TBL] [Abstract][Full Text] [Related]
5. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
[TBL] [Abstract][Full Text] [Related]
6. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.
Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM
Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529
[TBL] [Abstract][Full Text] [Related]
7. High resolution melting for mutation scanning of TP53 exons 5-8.
Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
[TBL] [Abstract][Full Text] [Related]
8. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.
Sambuughin N; Holley H; Muldoon S; Brandom BW; de Bantel AM; Tobin JR; Nelson TE; Goldfarb LG
Anesthesiology; 2005 Mar; 102(3):515-21. PubMed ID: 15731587
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
[TBL] [Abstract][Full Text] [Related]
10. DNA testing for malignant hyperthermia: the reality and the dream.
Stowell KM
Anesth Analg; 2014 Feb; 118(2):397-406. PubMed ID: 24445638
[TBL] [Abstract][Full Text] [Related]
11. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations.
Milbury CA; Li J; Makrigiorgos GM
Clin Chem; 2009 Dec; 55(12):2130-43. PubMed ID: 19815609
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
14. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
15. [Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia].
Wolak S; Rücker B; Kohlschmidt N; Doetsch S; Bartsch O; Zechner U; Tzanova I
Anaesthesist; 2014 Sep; 63(8-9):643-50. PubMed ID: 25047158
[TBL] [Abstract][Full Text] [Related]
16. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay.
Cousins MM; Donnell D; Eshleman SH
J Mol Diagn; 2013 Jan; 15(1):130-7. PubMed ID: 23178437
[TBL] [Abstract][Full Text] [Related]
17. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
18. Development of a rapid high-throughput method for high-resolution melting analysis for routine detection and genotyping of noroviruses.
Tajiri-Utagawa E; Hara M; Takahashi K; Watanabe M; Wakita T
J Clin Microbiol; 2009 Feb; 47(2):435-40. PubMed ID: 19073870
[TBL] [Abstract][Full Text] [Related]
19. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
[TBL] [Abstract][Full Text] [Related]
20. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
